Is 2530.HK overvalued or undervalued?

2530.HK currently has a P/E ratio of 7.85. Relative to the sector average of 22.40, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Numans stock?

Numans trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 2530.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 2530.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 2530.HK to protect their purchasing power. Because 2530.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 2530.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 2530.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 2530.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks2530.HK

Numans

HK$0.72+HK$0.00+0.00%

HKSE / HKD

Market cap

HK$720M

P/E

7.8

EPS (TTM)

HK$0.01

Dividend yield

3.50%

Beta

-0.40

1Y return

+24.14%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$52M2021

$54M2022

$60M2023

$39M2024

$26M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.01Low
Current ratio12.64
Cash ratio6.56
Net margin31.0%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

2530.HK7.8
Consumer Defensive sector median22.4
S&P 50022.0

Trades about 65% below its sector, cheaper than its peers on earnings.

Ratios

PEG0.17
Price to book1.20
EPS (TTM)HK$0.01
Payout ratio9,522%
FCF yield8.45%

Range & risk

HK$0.45HK$0.83

Trading in the upper third of its 52-week band

Beta-0.40

Profile

What Numans actually does

Numans Health Food Holdings Company Limited focuses on the marketing, sale, and distribution of its Nemans-branded nutritional supplements across the People's Republic of China. Their extensive product range features algal oil docosahexaenoic acid (DHA), which supports brain and eye development in infants and children, and helps alleviate forgetfulness, anxiety, and postpartum depression in mothers. The company also offers probiotics, including solid drinks and lactic acid bacteria powders, to improve digestion and boost immunity for all ages. Other offerings include various vitamin and multi-nutrient products specifically formulated for pregnant women, infants, and children, as well as algal calcium and milk powders for diverse age groups. These products are distributed to consumers through both online platforms and traditional retail outlets. Established in Shanghai in 2002, Numans is a wholly-owned subsidiary of Far-East Fortune Management (China) Co., Ltd.

CEO

Ping Wang

Employees

Headquarters

Shanghai, GD

Founded

2025-01-10

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 2530.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

2530.HK has a beta of -0.40, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Numans